AZD9592 targets EGFR and c-MET on the cell surface, is internalized, and releases a TOP1 inhibitor that induces DNA breaks and apoptosis. TOP1 is the intracellular payload target, not the recognition antigen, so TOP1-expressing cells are not selectively killed unless they also express EGFR/c-MET.